<qa>  What is the name of the group that augmented Berlin-Frankfurt-MüI. To determine, through randomization, the relative safety and efficacy of the addition of nelarabine Compound 506U78 to augmented Berlin-Frankfurt-Münster BFM therapy Regimen C, Childrens Cancer Group CCG-1961. 